ISO 9001:2015 Certified
Live Customer Support
4.5/5 on Trustpilot
100% Quality Guarantee

Lupartumab Biosimilar - Anti-LYPD3 Antibody - BSA and Azide free (A338828)

Recombinant human monoclonal antibody to LYPD3 for use as a research grade Lupartumab biosimilar for ELISA, Flow Cytometry, Functional Studies and in vivo Research.

Shipping Information

$40
Dispatched from St. Louis, MO.
Lead Time: 7-10 business days.
Name
Lupartumab Biosimilar - Anti-LYPD3 Antibody - BSA and Azide free
Description
Recombinant human monoclonal antibody to LYPD3 for use as a research grade Lupartumab biosimilar.
Applications
ELISA, Flow Cytometry, Functional Studies, in vivo Research
Reactivity
Human
Host
Human
Clonality
Monoclonal
Isotype
IgG1
Conjugate

Unconjugated

Purity
The purity of this Biosimilar is >95%, as determined by SDS-PAGE.
Product Form
Liquid
Formulation
Supplied in 0.01M Phosphate Buffered Saline, pH 7.4.
Storage
Shipped at 4°C. Upon delivery store at 4°C for short-term use (1-2 weeks) or aliquot and store at -20°C for long-term use (up to 12 months).
Synonyms
C4.4A, GPI-anchored metastasis-associated protein C4.4A homolog, Ly6/PLAUR domain-containing protein 3, Matrigel-induced gene C4 protein, MIG-C4
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Lupartumab Biosimilar - Anti-LYPD3 Antibody - BSA and Azide free (A338828)? Please let us know so that we can list the citation on this page.

Alternative products to Lupartumab Biosimilar - Anti-LYPD3 Antibody - BSA and Azide free (A338828)

Proteins predicted to interact with LYPD3

Predicted protein interactions based upon String database. Revelancy score correlates with probability of interaction.
98.4% Relevancy Score
91.4% Relevancy Score
75.6% Relevancy Score
70.4% Relevancy Score
55.9% Relevancy Score
55.5% Relevancy Score
53.6% Relevancy Score
52.5% Relevancy Score
52.2% Relevancy Score